These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4278371)

  • 1. [The activity of 17 beta-hydroxysteroid-oxidoreductase in erythrocytes of psoriatics (author's transl)].
    Morsches B; Hoffmann-Trefz G; Hoffmann G; Oertel GW; Holzmann H
    Arch Dermatol Forsch; 1974; 250(3):269-75. PubMed ID: 4278371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioimmunoassay of dehydroepiandrosterone and 5-androstene-3-beta, 17-beta-diol in the plasma of psoriatics and controls].
    Morsches B; Benes P; Holzmann H
    Arch Dermatol Res; 1979 Oct; 266(2):181-5. PubMed ID: 160776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Family studies for detection of latent psoriatics by assay of alterations in steroid metabolism (author's transl)].
    Holzmann H; Hoffmann G; Schwarz P; Morsches B; Oertel GW; Fränz J
    Arch Dermatol Forsch; 1975; 252(2):151-9. PubMed ID: 125074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Profiles in chronic diseases. I. Investigations of steroid profiles in uremia (author's transl)].
    Ludwig H; Spiteller G; Matthaei D; Scheler F
    J Chromatogr; 1978 Nov; 146(3):381-91. PubMed ID: 152768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunoassay of dehydroepiandrosterone and 5-androsten-3 beta, 17 beta-diol (author's transl)].
    Benes P; Morsches B; Holzmann H
    J Clin Chem Clin Biochem; 1980 Feb; 18(2):117-22. PubMed ID: 6445401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiopathogenesis of the psoriatic disease].
    Holzmann H; Morsches B; Hoede N
    Med Welt; 1973 Mar; 24(12):429-34. PubMed ID: 4349558
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penetration kinetics of dehydroepiandrosterone through the erythrocyte membrane (author's transl)].
    Morsches B; Benes P; Holzmann H; Henrich B
    Arch Dermatol Res; 1981; 270(1):49-55. PubMed ID: 6455097
    [No Abstract]   [Full Text] [Related]  

  • 8. Augmented glucose-6-phosphate dehydrogenase activity and normal penetration and metabolism of dehydroepiandrosterone in mononuclear leukocytes in psoriasis.
    Schopf RE; Müller FJ; Benes P; Morsches B
    Arch Dermatol Res; 1986; 278(5):393-7. PubMed ID: 2944486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of 17beta-hydroxysteroid dehydrogenase from human red blood cells.
    Jacobsohn GM; O'Rangers JJ
    Arch Biochem Biophys; 1974 Apr; 161(2):384-94. PubMed ID: 4151981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of psoriasis with dehydroepiandrosterone-enanthate. II. Intramuscular depot application of 300 mg weekly (author's transl)].
    Holzmann H; Morsches B; Krapp R; Hoede N; Oertel GW
    Arch Dermatol Forsch; 1973; 247(1):23-8. PubMed ID: 4270566
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of free and conjugated steroids by intact and hemolysed mammalian erythrocytes.
    Mulder E; Lamers-Stahlhofen GJ; van der Molen HJ
    Biochim Biophys Acta; 1972 Feb; 260(2):290-7. PubMed ID: 4259003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dehydroepiandrosterone deficiency in psoriasis. Hypothesis on the etiopathogenesis of this disease].
    Holzmann H; Benes P; Morsches B
    Hautarzt; 1980 Feb; 31(2):71-5. PubMed ID: 6447124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and urinary steroids in an eight-year-old boy with 3-beta-hydxysteroid dehydrogenase deficiency.
    Jänne O; Perheentupa J; Vihko R
    J Clin Endocrinol Metab; 1970 Aug; 31(2):162-5. PubMed ID: 4246521
    [No Abstract]   [Full Text] [Related]  

  • 14. Model studies with erythrocytes on the initial steps of cellular uptake and binding of steroids.
    Brinkmann AO; Mulder E; Van der Molen HJ
    J Steroid Biochem; 1972 Apr; 3(3):601-15. PubMed ID: 4343493
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation of 3 beta,20 alpha-hydroxysteroid oxidoreductase from sheep fetal blood.
    Chen QX; Nancarrow CD; Sweet F
    Steroids; 1987 Jun; 49(6):477-96. PubMed ID: 3483295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophoretical determinations of glucose-6-phosphate-dehydrogenase in erythrocytes of psoriatic patients (author's transl)].
    Holzmann H; Ananthakrishnan R; Eckes L; Morsches B; Walter H; Hoede N
    Arch Dermatol Forsch; 1973 Sep; 247(3):283-8. PubMed ID: 4748774
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of androgens in patients with congenital adrenal hyperplasia.
    Rivarola MA; Saez JM; Migeon CJ
    J Clin Endocrinol Metab; 1967 May; 27(5):624-30. PubMed ID: 4225893
    [No Abstract]   [Full Text] [Related]  

  • 18. [C19-steroids in psoriasis].
    Menzel P; Morsches B; Bregenzer M; Holzmann H; Oertel GW
    Acta Endocrinol Suppl (Copenh); 1971; 152():11. PubMed ID: 4251531
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of psoriasis using dehydroepiandrosterone-sulfate].
    Holzmann H; Krapp R; Morsches B; Hoffmann G; Oertel GW
    Arztl Forsch; 1971 Nov; 25(11):345-53. PubMed ID: 4331248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Specificity of 3 alpha, 20 beta-hydroxysteroid: nad+ -oxidoreductase (author's transl)].
    Allner R; Eggstein M
    J Clin Chem Clin Biochem; 1976 Feb; 14(2):59-64. PubMed ID: 175129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.